ddp4 inhibitor and glp 1 agonist How does sitagliptin work? DPP-4 inhibitors GLP-1 mimetics Renoprotective Effects of DPP-4 Inhibitors
Description
Hansotia, T
Hao Xu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
The drugs are also effective in promoting weight loss if taken according to their treatment plan, which means patients should take the drugs continuously for at least 12 weeks
Example in development - Triple agonists targeting GLP-1, GIP, and glucagon are in early trials
Doctors can prescribe pramlintide off label for weight loss, but it is not officially approved for this use
Proactive risk mitigation strategies can minimize gastroparesis-related complications in patients prescribed GLP-1 receptor agonists
